Psychopathology and eating disorders in patients with psoriasis

Giornale Italiano di Dermatologia e Venereologia

Volumn 149, Issue 3, 2014, Pages 355-361

  Crosta, M L ^a   Caldarola, G ^a   Fraietta, S ^a   Craba, A ^a   Benedetti, C ^a   Coco, V ^a   Janiri, L ^a   Rinaldi, L ^a   De Simone, C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Eating disorders; Obesity; Psoriasis; Psychopathology

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EATING DISORDER; EATING DISORDER INVENTORY; FEEDING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SYMPTOM CHECKLIST 90;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; EATING DISORDERS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PSORIASIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84905669766     PISSN: 03920488     EISSN: 18271820     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Daudén E, Castañeda S, Suárez C, García- Campayo J, Blasco AJ, Aguilar MD et al. Integrated approach to comorbidity in patients with psoriasis. Working Group on Psoriasis-associated Comorbidities. Actas Dermosifiliogr 2012;1:1-64.
2. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298:321-8.
3. Rahat SA, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008;20:416-22.
4. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007;25:529-34. (Pubitemid 350087599)
5. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med 2009;122:1-9.
6. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012;2:e54.
7. Paller AS, Mercy K, Kwasny MJ, Choon SE, Cordoro KM, Girolomoni G et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol 2013;149:166-76.
8. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007;157:649-55. (Pubitemid 47389868)
9. Bremmer S, Van Voorhees AS, Hsu S, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010;63:1058-69.
10. Stunkard AJ. Eating disorders and obesity. Psychiatr Clin North Am 2011;34:765-71.
11. Villarejo C, Fernández-Aranda F, et al. Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur Eat Disord Rev 2012;20:250-4.
12. th edition, Washington, DC, USA; 2012.
13. Rieger E, Wilfley DE, Stein RI, Marino V, Crow SJ. A comparison of quality of life in obese individuals with and without binge eating disorder. Int J Eat Disord 2005;37:234-40. (Pubitemid 40628238)
14. Wilfley DE, Wilson GT, Agras WS. The clinical significance of binge eating disorder. Int J Eat Disord 2003;34:S96-S106. (Pubitemid 36935717)
15. Haves J, Koo J. Psoriasis: depression, anxiety, smoking and drinking habits. Dermatol Ther. 2010;23:174-80.
16. Kurd SK, Troxel AB, Crits-Christoph P. The risk of depression, anxiety and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010;146:891-5.
17. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004;45:155-9.
18. Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009;121:154-61.
19. Misery L. Depression and psoriasis. Ann Dermatol Venereol 2012;139:S53-7.
20. Kieć-Swierczyńska M, Dudek B, Krecisz B, Swierczyńska-Machura D, Dudek W, Gamczarek A et al. The role of psychological factors and psychiatric disorders in skin diseases. Med Pr. 2006; 57:551-5.
21. Parafianowicz K, Sicińska J, Moran A, Szumański J, Staniszewski K, Rudnicka L et al. Psychiatric comorbidities of psoriasis: pilot study Psychiatr Pol 2010;44:119-26.
22. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003;4:833-42. (Pubitemid 38030859)
23. G Savron, R Montanaro, G Landi, G Bartolucci. Psychological aspects of patients with psoriasis and alopecia areata: a controlled study. Rivista di psichiatria 2001;36:135-45.
24. Altunay I, Demirci GT, Ates B, Kucukunal A, Aydin C, Karamustafahoglu O et al. Do eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary study. Clin Cosmet Investig Dermatol 2011;4:139-43.
25. Kimball AB, Wu EQ, Guérin A, Yu AP, Tsaneva M, Gupta SR et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol 2012;67:651-7.e1-2.
26. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44. (Pubitemid 8387357)
27. Garner DM, Olmsted MP, Polivy J. Development and validation of a multidimensional Eating Disorder Inventory for anorexia nervosa and bulimia. Int J Eating Dis 1983;2:15-34.
28. Milos G, Spindler A, Schnyder U. Psychiatric comorbidity and Eating Disorder Inventory (EDI) profiles in eating disorder patients. Can J Psychiatry 2004;49:179-80.
29. Derogatis LR. SCL-90-R, administration, scoring and procedures manual for the Revised version. Baltimore. Johns Hopkins University, School of Medicine; 1977.
30. Schauenburg H, Strack M. Die Symptom-Checklist-90-R zur darstellung von statistischen und klinisch signifikanten psychotherapie-ergebnissen. Psychother Psychosom Med Psychol 1998;48:257-64.
31. Schauenburg H, Strack M. Measuring psychotherapeutic change with the symptom checklist SCL-90-R. Psychother Psychosom 1999;68:199-206.
32. Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol 2012;51:12-26.
33. Anzieu D. L'lo-pelle. Rome: Borla; 1987.
34. Anzieu D. L'epidermide nomade e la pelle psichica. Milan: Cortina; 1992.
35. Anzieu D. II pensare. Dall'Io-pelle all'Io pensante, Borla, Roma 1996;
36. Anzieu D. Gli involucri psichici. Milan: Masson; 1997.
37. Elomaa AP, Niskanen L, Herzig KH, Viinamäki H, Hintikka J, Koivumaa-Honkanen H et al. Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC Psychiatry 2012;9:12:22.